The latest research has identified FGL1 as an immune inhibitory ligand of LAG-3, an immune inhibitory receptor that mediates T-cell suppression. Blocking FGL1/LAG-3 interaction improves anti-tumor immunity. Creative BioMart has currently developed FGL1 proteins from multiple species. Their binding activity with LAG-3 protein has been verified by functional ELISA. https://www.creativebiomart.net/resource/pdfdownload/dbd8e3ddfc158995b7e56f7277140c50.pdf